Patent ID: 8153817

Claim:
A process for converting methyl nonactate into a triazoloamide antibacterial agent comprising (1) inverting the secondary alcohol of the methyl nonactate to produce the corresponding azidoester, (2) converting the azido ester to the corresponding azidoamide, and (3) converting the azido group of the azidoamide to a triazole to produce the corresponding triazoloamide, wherein the triazoloamide is of the formula where R 1 , R 2 and R 3 are independently H, a C 1 -C 12 aliphatic or aromatic group, a 5 or 6 membered ring, a condensed polynuclear aliphatic or an aromatic 5 or 6 membered ring, these rings optionally containing one or more N or O heteroatoms or both, such rings also being optionally substituted with various pendant groups including C 1 -C 12 aliphatic and aromatic hydrocarbon groups, and C 1 -C 12 ethers.